Home / Research library / AOD-9604
AOD-9604: molecular data, studies & sources
AOD-9604 is catalogued here as a research compound. This profile brings together the molecular source record, selected indexed publications and available supplier comparisons. Evidence for a named substance does not authenticate a commercial product.
Compiled by PeptideTech Editors · Sources checked · Selected bibliography, not a systematic review
Molecular formula, weight & structure
- Molecular formula (MF)
- C78H123N23O23S2
- Molecular weight (MW)
- 1815.1 g/mol
- PubChem compound ID
- 71300630
- Record title
- Aod-9604
Values describe the selected PubChem molecular entity. Counterions, salt forms, hydration and sequence changes can alter the supplied material. Confirm the exact identity against the supplier specification.
Source: PubChem CID 71300630 · retrieved 2026-09-21

Chemical identifiers and source data
- IUPAC name
- (2S)-2-[[2-[[(4R,7S,13S,16S,19S,22S,25R)-25-[[(2S)-5-amino-2-[[(2S)-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]-4-methylpentanoyl]amino]-5-carbamimidamidopentanoyl]amino]-3-methylpentanoyl]amino]-3-methylbutanoyl]amino]-5-oxopentanoyl]amino]-22-(3-carbamimidamidopropyl)-13-(2-carboxyethyl)-7,19-bis(hydroxymethyl)-6,9,12,15,18,21,24-heptaoxo-16-propan-2-yl-1,2-dithia-5,8,11,14,17,20,23-heptazacyclohexacosane-4-carbonyl]amino]acetyl]amino]-3-phenylpropanoic acid
- InChIKey
- GVIYUKXRXPXMQM-BPXGDYAESA-N
- SMILES
- CC[C@H](C)[C@@H](C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@H]1CSSC[C@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCCNC(=N)N)CO)C(C)C)CCC(=O)O)CO)C(=O)NCC(=O)N[C@@H](CC2=CC=CC=C2)C(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC3=CC=C(C=C3)O)N
Identifiers & sequence
- PubChem CID
- 71300630
- CAS Registry Number
- 221231-10-3via ChemIDplus, EPA DSSTox, FDA GSRS
- FDA UNII
- 7UP768IP4M
- InChIKey
- GVIYUKXRXPXMQM-BPXGDYAESA-N
Peptide sequence · 16 residues (one-letter code; X marks a residue without a one-letter code)
YLRIVQCRSVEGSCGF
Condensed notation with terminal groups and non-standard residues
H-Tyr-Leu-Arg-Ile-Val-Gln-Cys(1)-Arg-Ser-Val-Glu-Gly-Ser-Cys(1)-Gly-Phe-OH
Source: PubChem Biologic Line Notation. A reference sequence for the record, not an analysis of a supplied batch.
CAS numbers are published only from ChemIDplus, EPA DSSTox or the FDA Global Substance Registration System; UNII codes are confirmed in FDA GSRS by structure, sequence or exact name. Checked 2026-10-07.
Calculated molecular descriptors
| Monoisotopic (exact) mass | 1813.8604 Da |
|---|---|
| Heavy atoms | 126 |
| Hydrogen-bond donors | 28 |
| Hydrogen-bond acceptors | 26 |
| Rotatable bonds | 43 |
| Topological polar surface area | 764.7 Ų |
| Calculated logP (Crippen) | -7.44 |
| Rings | 3 |
| Stereocenters | 15 |
| Formal charge | 0 |
Computed with RDKit from the published SMILES (Crippen logP, topological polar surface area). Calculated descriptors are not measured properties of a supplied batch.
Registered clinical trials
Studies registered on ClinicalTrials.gov that list AOD-9604 as an intervention. Studies that only measure the molecule as a biomarker, or use it only as a comparator or background arm for another drug, are excluded. A registration describes a planned or completed protocol; it does not report a result. Active studies are listed first.
No registered study naming this compound was matched. This is a documented gap in registry coverage, not proof that no study exists.
Registry check 2026-10-01 · Run this search on ClinicalTrials.gov
Human intervention studies
Selected studies in which participants received AOD-9604, with their indexed or reviewed study type. Check the original article for the formulation, population and controls. Studies that only measured the molecule, or used it as a comparator, are listed separately below and are not counted as intervention studies.
No human study that administered this compound was retained in this selected bibliography. This is a documented evidence gap in our selection, not proof that no study exists.
Preclinical research, reviews & other publications
Animal studies, laboratory experiments, reviews and other indexed papers answer different questions. A review is secondary evidence; a case report does not estimate how often an outcome occurs.
- Review · secondary evidence
AOD-9604 Metabolic.
Wilding J · Current opinion in investigational drugs (London, England : 2000) · 2004
PMID 15134286
- Research publication · design requires review
AOD-9604 does not influence the WADA hGH isoform immunoassay.
Orlovius AK, Thomas A, Schänzer W et al. · Drug testing and analysis · 2013
PMID 24124033 · DOI: 10.1002/dta.1557
AOD-9604 supplier sources
Scientific sources describe molecules and experiments. The commercial links below identify recorded supplier packages. A publication or chemical database entry does not verify the seller, purity, sterility or contents of a lot. Some links are affiliate links; see our disclosure.
AOD-9604 for sale: compare prices, sizes and forms from every tracked supplier →
| Supplier | Recorded packages | Example source listing |
|---|---|---|
| Blank PeptidesUSD | 5mg Vial1 recorded offers | 5mg Vial · $65.00Stale observation · Checked Sep 30, 2026Supplier listing, AOD-9604 5mg Vial, Blank Peptides, opens in a new tab |
| American PeptidesUSD | 5mg Vial1 recorded offers | 5mg Vial · $60.00Checked Nov 6, 2026Supplier listing, AOD-9604 5mg Vial, American Peptides, opens in a new tab |
| Amino ClubUSD | 5mg Vial1 recorded offers | 5mg Vial · $49.99Stale observation · Checked Oct 14, 2026Supplier listing, AOD-9604 5mg Vial, Amino Club, opens in a new tab |
| Nova Peptide SupplyUSD | 5mg Vial1 recorded offers | 5mg Vial · $49.99Checked Nov 6, 2026Supplier listing, AOD-9604 5mg Vial, Nova Peptide Supply, opens in a new tab |
| Cenexa LabsUSD | 5mg Vial1 recorded offers | 5mg Vial · $49.99Checked Nov 3, 2026Supplier listing, AOD-9604 5mg Vial, Cenexa Labs, opens in a new tab |
| LA PeptidesUSD | 10mg Vial1 recorded offers | 10mg Vial · $49.99Checked Nov 3, 2026Supplier listing, AOD-9604 10mg Vial, LA Peptides, opens in a new tab |
Reference sources & further reading
- PubChem compound record 71300630 — chemical identity and structure.
- FDA Global Substance Registration System: UNII 7UP768IP4M — substance identity, names and codes.
- Wikipedia: AOD9604 — Background encyclopedia; not a primary clinical source.
The citations above link directly to publication records. Encyclopedia links are background reading and are not used to establish clinical effectiveness.
Search for additional research
These links run searches; their results have not been individually reviewed and can include unrelated compounds.
Research information is not a dosing guide or a recommendation for personal use. Study findings are specific to the formulation, population and methods tested. Read our source and correction policy.
Related research profiles
ARA-290
C51H84N16O21
1257.3 g/mol · PubChem CID 91810664
7 selected publications · 3 human intervention studies · 2 registered trials
Protein / peptide · highest stage: Phase 2
BPC-157
C62H98N16O22
1419.5 g/mol · PubChem CID 9941957
7 selected publications · 1 human intervention study · 3 registered trials
Protein / peptide · highest stage: Phase 1
KPV
C16H30N4O4
342.43 g/mol · PubChem CID 125672
8 selected publications · 0 human intervention studies
LL-37
C205H340N60O53
4493 g/mol · PubChem CID 16198951
4 selected publications · 0 human intervention studies · 2 registered trials
PTD-DBM
Molecular identity needs further verification
3 selected publications · 0 human intervention studies
TB-500
Molecular identity needs further verification
1 selected publication · 0 human intervention studies · 1 registered trial